Squarepoint
ORGS

Squarepoint’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Squarepoint’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,316
Closed -$115K – 3607
2021
Q3 		$115K Sell
2,316
-1,150
-33% -$57.7K ﹤0.01% 2640
2021
Q2 		$176K Buy
+3,466
New +$175K ﹤0.01% 2878
2021
Q1 		– Sell
-1,652
Closed -$74K – 3726
2020
Q4 		$74K Sell
1,652
-666
-29% -$32.1K ﹤0.01% 2764
2020
Q3 		$117K Buy
+2,318
New +$126K ﹤0.01% 2252
2019
Q2 		– Sell
-1,932
Closed -$103K – 2734
2019
Q1 		$103K Buy
+1,932
New +$96.4K ﹤0.01% 2038

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RC
Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BHB
Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Squarepoint's ORGS Position: Q4 2021 in Review

Squarepoint sold out of Orgenesis Inc. Common Stock (ORGS) in Q4 2021, closing a stake of 2,316 shares — an estimated $115K sold.

Squarepoint first reported a position in ORGS in Q1 2019 and held it in 5 quarters. The position peaked at $176K in Q2 2021. 26 funds tracked by Wall St. Rank hold ORGS as of Q4 2021.

  • Squarepoint reported no remaining Orgenesis Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Squarepoint sold 2,316 Orgenesis Inc. Common Stock shares in Q4 2021, an estimated $115K.
  • Squarepoint first reported a position in Orgenesis Inc. Common Stock in Q1 2019 and held it in 5 quarters.
  • Squarepoint's Orgenesis Inc. Common Stock position peaked at $176K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q4 2021.

Based on Squarepoint's 13F filing for Q4 2021, filed 14 Feb 2022.